Core Laboratories (MEX:CLB) Cyclically Adjusted Revenue per Share: MXN756.92 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:CLB Core Laboratories Inc MEX:CLB
62 GF Score
Price MXN856.38
GF Value MXN1,333.14
! 3 Warning Signs
View Full Analysis

What is Core Laboratories Cyclically Adjusted Revenue per Share?

Core Laboratories MEX:CLB 62 Cyclically Adjusted Revenue per Share is MXN756.92 as of Mar. 2026. GuruFocus rates MEX:CLB with a GF Score™ of 62/100 and a GF Value™ of MXN1,333.14. The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Core Laboratories's adjusted revenue per share for the three months ended in Mar. 2026 was MXN47.671. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is MXN756.92 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Core Laboratories's average Cyclically Adjusted Revenue Growth Rate was -4.80% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -7.60% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was -5.40% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was -2.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Core Laboratories was 14.70% per year. The lowest was -7.60% per year. And the median was 5.90% per year.

As of today (2026-07-15), Core Laboratories's current stock price is MXN856.38. Core Laboratories's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was MXN756.92. Core Laboratories's Cyclically Adjusted PS Ratio of today is 1.13.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Core Laboratories was 6.51. The lowest was 0.43. And the median was 1.37.


Core Laboratories  (MEX:CLB) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Core Laboratories's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=856.38/756.92
=1.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Core Laboratories was 6.51. The lowest was 0.43. And the median was 1.37.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Core Laboratories Cyclically Adjusted Revenue per Share Related Terms


Core Laboratories Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Core Laboratories's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Core Laboratories Cyclically Adjusted Revenue per Share Chart

Core Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 735.47 793.85 844.74 781.18 790.67

Core Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 890.66 1,141.84 1,047.61 790.67 756.92

MEX:CLB vs EROK, OIS, NGS: Cyclically Adjusted Revenue per Share Comparison

For the Oil & Gas Equipment & Services subindustry, Core Laboratories's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Core Laboratories Cyclically Adjusted PS Ratio vs Oil & Gas Industry

For the Oil & Gas industry and Energy sector, Core Laboratories's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Core Laboratories's Cyclically Adjusted PS Ratio falls into.


MEX:CLB
62GF Score
Core Laboratories Inc MEX:CLB
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Core Laboratories Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Core Laboratories's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=47.671/330.2130*330.2130
=47.671

Current CPI (Mar. 2026) = 330.2130.

Core Laboratories Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 62.943 241.018 86.237
201609 62.597 241.428 85.617
201612 67.452 241.432 92.256
201703 66.494 243.801 90.062
201706 64.449 244.955 86.881
201709 66.680 246.819 89.210
201712 75.677 246.524 101.368
201803 69.469 249.554 91.922
201806 77.495 251.989 101.551
201809 76.406 252.439 99.946
201812 76.897 251.233 101.071
201903 73.368 254.202 95.306
201906 72.454 256.143 93.406
201909 76.467 256.759 98.343
201912 66.624 256.974 85.612
202003 80.399 258.115 102.856
202006 60.073 257.797 76.948
202009 51.850 260.280 65.781
202012 50.849 260.474 64.463
202103 48.200 264.877 60.089
202106 50.182 271.696 60.990
202109 51.480 274.310 61.971
202112 55.492 278.802 65.725
202203 49.586 287.504 56.952
202206 51.593 296.311 57.496
202209 53.897 296.808 59.963
202212 53.626 296.797 59.664
202303 48.727 301.836 53.308
202306 46.158 305.109 49.956
202309 45.865 307.789 49.206
202312 45.832 306.746 49.338
202403 45.102 312.332 47.684
202406 50.105 314.175 52.663
202409 55.339 315.301 57.956
202412 56.541 315.605 59.158
202503 54.055 319.799 55.815
202506 51.744 322.561 52.972
202509 52.417 324.800 53.291
202512 54.056 324.054 55.083
202603 47.671 330.213 47.671

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of MXN756.92 mean?
Core Laboratories (MEX:CLB) has a Cyclically Adjusted Revenue per Share of MXN756.92 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Core Laboratories and its competitors.
Is Core Laboratories' Cyclically Adjusted Revenue per Share too high?
Core Laboratories' current Cyclically Adjusted Revenue per Share is MXN756.92. Overall, Core Laboratories has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does Core Laboratories' Cyclically Adjusted Revenue per Share compare to EROK and OIS?
Core Laboratories' Cyclically Adjusted Revenue per Share of MXN756.92 can be compared against companies in the Oil & Gas industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for an Oil & Gas company?
A good Cyclically Adjusted Revenue per Share depends on the Oil & Gas industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Core Laboratories and its competitors. Core Laboratories's current Cyclically Adjusted Revenue per Share is MXN756.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Core Laboratories stock overvalued right now?
Core Laboratories (MEX:CLB) has a current Cyclically Adjusted Revenue per Share of MXN756.92. The stock's GF Value™ is MXN1,333.14, compared to a current price of MXN856.38 — trading 35.8% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is MXN756.92. Core Laboratories' overall GF Score™ is 62/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Core Laboratories (MEX:CLB), the current Cyclically Adjusted Revenue per Share is MXN756.92 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Core Laboratories (MEX:CLB) Overvalued in 2026?

Based on GuruFocus' analysis, Core Laboratories stock appears to be undervalued. The current stock price of MXN856.38 is trading 35.8% below its estimated GF Value™ of MXN1,333.14.

Key valuation signals for MEX:CLB:

  • Cyclically Adjusted Revenue per Share: MXN756.92
  • GF Value™: MXN1,333.14 vs. price of MXN856.38 (35.8% below fair value)
  • GF Score™: 62/100 with 3 warning signs

No single metric tells the full story. See the MEX:CLB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Core Laboratories Business Description

Industry EnergyOil & Gas
Other Exchanges CLB:USAHJ1:Germany
Address 6316 Windfern Road, Houston, TX, USA, 77040
Core Laboratories Inc is a providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry, through client relationships. The company operates its business in two segments; Reservoir Description, and Production Enhancement. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services. The company generates majority of its revenue from Reservoir Description segment.
62GF Score

Get the complete analysis for MEX:CLB

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN856.38
Price
MXN1,333.14
GF Value